A novel SOS1 mutation in Costello/CFC syndrome affects signaling in both RAS and PI3K pathways

Munkhtuya Tumurkhuu1, Makiko Saitoh, Junko Takita

  • 1Department of Developmental Medical Sciences, Institute of International Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Abstract

Insights

A novel Son of Sevenless 1 (SOS1) mutation (T158A) enhances RAS/MAPK signaling and impacts PI3K/AKT pathways. This finding sheds light on Costello, Noonan, and CFC syndromes.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Genetics

Background:

  • RAS/MAPK pathway dysregulation underlies Costello, Noonan, and cardio-facio-cutaneous (CFC) syndromes.
  • The role of PI3K/AKT signaling in these conditions remains largely unexplored.
  • A novel SOS1 (T158A) mutation was identified in a patient with overlapping Costello/CFC phenotypes.

Purpose of the Study:

  • To investigate the impact of the SOS1 (T158A) mutation on both RAS/MAPK and PI3K/AKT signaling pathways.
  • To elucidate the functional consequences of this mutation in cellular signaling.

Main Methods:

  • Wild-type and mutant (T158A) Son of Sevenless 1 (SOS1) were expressed in 293T cells.
  • Cells were stimulated with epidermal growth factor (EGF).
  • Phosphorylation levels of ERK1/2, AKT, p70S6K, and pS6 were quantified.

Main Results:

  • The SOS1 (T158A) mutation accelerated and prolonged ERK1/2 phosphorylation following EGF stimulation.
  • Mutant SOS1 cells exhibited reduced phospho-AKT levels at 60 minutes post-stimulation.
  • Differential phosphorylation patterns of p70S6K were observed between wild-type and mutant SOS1 cells.
  • Elevated phospho-ERK1/2 to total ERK1/2 ratio persisted in mutant cells 18 hours post-EGF, while phospho-AKT levels remained unchanged.

Conclusions:

  • The T158A mutation in the SOS1 histone-like domain may disrupt auto-inhibition, leading to enhanced RAS signaling.
  • The mutation influences PI3K/AKT pathway activity, potentially through negative feedback mechanisms involving phospho-p70S6K.
  • The SOS1 T158A mutation alters gene product phosphorylation in both RAS/MAPK and PI3K/AKT pathways, contributing to disease phenotypes.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...